The FDA has accepted the New Drug Application for ET-600, an oral solution formulation of desmopressin, for the treatment of central diabetes insipidus.

Marketing Areas Explore our expert-led B2B marketing guides, reports, podcasts and articles. Search and filter by your chosen B2B specialism. Marketing AreasABM & Demand GenerationBrandChannel ...

Fees waived for Adopt-a-Pet Day, summer shelter hours extended By Linda Mcintosh June 6, 2025 at 10:32 a.m.